Le Lézard
Classified in: Health, Science and technology
Subjects: NEW PRODUCTS/SERVICES, CALENDAR OF EVENTS, TRADE SHOWS/SEMINARS/WEBINARS

TeraRecon Debuts New AI Synctm Technology


CHICAGO, Dec. 01, 2019 (GLOBE NEWSWIRE) -- Artificial intelligence and advanced visualization leader, TeraRecon, today introduced AI Synctm results interchange technology for seamless delivery of interactive AI findings into the report and downstream systems, as well as connecting multiple algorithms for sophisticated ensemble AI workflows. AI Sync is incorporated into the full range of TeraRecon products on display at the Radiological Society of North America's (RSNA)105th Annual Scientific Assembly this week in Chicago, Illinois at TeraRecon Booth #8313.

AI Sync technology is a new software enhancement to the EnvoyAItm platform which is renowned for its integrated AI workflow based on personalized clinical feedback from each physician. With workflow preferences that are curated through their actual use, AI Sync uses this information along with its powerful interoperability features to automatically prepare AI results and present them for verification before, during or after the radiologists' interpretations are completed ? all while keeping radiologists in complete control.

By using EnvoyAI as the enterprise-wide AI solution, radiologists can maintain control over what is conveyed to referring physicians. Through AI Sync technology, the AI-generated medical images that correlate to the AI findings are also synchronized with the PACS and metadata are saved in a structured database for future use.

"AI is not yet ready to do work by itself, and physicians today do not want unfettered AI results in their diagnostic reports or medical records. Doing so has a greater chance of doing clinical harm, than good. The real solution for AI workflow involves truly open access to the results from AI algorithms where physicians can work synchronously and iteratively in conjunction with the AI algorithms." says Jeff Sorenson, President and CEO, TeraRecon.  "There is very little truly new AI workflow technology out there. I recommend that customers focus on purpose-built new AI interoperability solutions that achieve wide access with elegant clinical integrations into the clinical workflow."

Explore TeraRecon's end-to-end AI ecosystem including AI Sync working in real-time with iNtuition, EnvoyAI and the Northstar AI Results Explorer by visiting TeraRecon (North Hall, booth #8313 and AI Showcase, #10710) at RSNA in Chicago, Illinois from December 1st-5th, 2019. 

About TeraRecon (www.terarecon.com) TeraRecon is a leader in medical advanced visualization and artificial intelligence solutions. Their flagship product, iNtuition, consistently leads the advanced visualization category of the industry's leading independent technology analyst. The company continues to innovate ahead of customer demand and has most recently developed sophisticated healthcare-focused artificial intelligence platform solutions unlike any in the world today. EnvoyAI was the recipient of the prestigious Aunt Minnie 2018 Best New Radiology Vendor award. TeraRecon's Northstar AI Results Explorer is the first and only enterprise-wide solution capable of delivering AI imaging insights directly and interactively into the systems clinicians use every day. As a company with a 20-year history of innovation, TeraRecon's mission is to continuously redefine medical advanced visualization and leverage artificial intelligence to improve patient care.

Press Inquiries US: 1-650-372-1100 | [email protected]

TeraRecon, iNtuition, EnvoyAI, Northstar AI Results Explorer and AI Sync are trademarks of TeraRecon, Inc.


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: